Protein Interface Targeted Aptamers Screened Using Competitive Selection
ISEF · 2016 Fourth Award
Overview
Nucleic acid aptamers are single stranded DNA or RNA that bind targets ranging from large biomolecules to small chemicals, with affinities and specificities emulating antibodies, and provide exciting prospects for basic science and therapeutic applications. This project sought to use a site specific aptamer evolution protocol, to tailor aptamers to a less conserved region of furin, a proprotein convertase (PC) in a large protease family implicated in a plethora of biological and pathological processes. Furin immobilization, stringency of aptamer binding and elution, strand separation and purification, and PCR amplification methods were first standardized. After several iterations of selection, the enriched aptamers were cloned and sequenced. Statistical analysis suggests that after four iterations of selection, the aptamer pool is purine enriched (p=0.006) with notable site-specific enrichments. Preliminary analyses suggest that selected aptamers display affinity, in the micromolar to nanomolar range, for the targeted interface, and further biochemical analysis continues.
Awards (1)
- Fourth Award of $500 $500
Competition history
- ISEF 2016
Resources
Related projects
ISEF · 2017
Aptamer Based Disruption of the CD47-SIRPa Interface for Anticancer Applications
CWSF · 2026
APTAi: De Novo Aptamer Design for Proteomic Biomarker Detection Using a Physics-Informed AI Model
JSHS · 2025
AI-Mediated Computational Analysis of RNA-Based Aptamers Targeting the CD133+ Glioblastoma Cells
ISEF · 2026
Harnessing RNA Nanotechnology: In silico Design and Structural Modeling of RNA Aptamers Targeting BRCA1 for Early Detection of Breast and Ovarian Cancer
CWSF · 2026
AptaBind AI: Using Artificial Intelligence to predict aptamer target binding.
ISEF · 2026
Designing a High-Affinity Peptide Binder to the BRD4 ET Domain to Outcompete MLV TP Utilizing ProteinMPNN and AF-CBA With Additional Molecular Dynamics Verification
ISEF · 2015
Inhibition of Cancer Cell Proliferation via G-Rich Oligonucleotides as Aptamer Nanosphere Bioconjugates
JSHS · 2022
In silico Design of APOBEC3G Inhibitors Through Site-Specific Fluorination of a ssDNA Oligonucleotide
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair